RentRedi Unveils First Ever Money-Back Guarantee, Raising the Bar for Landlord Confidence Orion will remain as the owner of pharmaceutical manufacturing plant in Kuopio, Finland
ORION CORPORATION Â Â Â Â Â Â Â Â Â PRESS RELEASE Â Â Â Â Â Â Â Â Â Â Â Â Â 17 AUGUST 2021 at 8.00. a.m. EEST Orion will…
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia
MELBOURNE, Australia and LONDON , Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022
Continued strength in unit demand across key product lines Rupall unit demand growth of 44%…
Chalice Brands Ltd. To Present at the Q3 Virtual Investor Summit
PORTLAND, Ore., Aug. 16, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings…
Celularity Reports Second Quarter 2021 Financial Results
Secured funding of approximately $138 million through merger and private placement investment in public equity…
Zogenix Reports Granting of Inducement Awards
EMERYVILLE, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX) today announced that the compensation…
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
Corvus Partner Angel Pharmaceuticals Plans to Initiate Trial by Year-end 2021 BURLINGAME, Calif., Aug. 16,…
Lowell Farms Inc. Announces Record Revenues and Record Cultivation Output for the Second Quarter
Lowell Reports 37% sequential growth in revenue driven by large cultivation yields advances and strong…
Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update
Groundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0,…
Ensysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative…
Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
Added Additional Treatment Arm and Provided Enrollment Update for Ongoing ELX-02 Phase 2 Clinical Trials…
Kinnate Biopharma Inc. Reports Second Quarter 2021 Financial Results
Announced first patient dosed in Phase 1 trial evaluating KIN-2787 in patients with BRAF mutation-positive solid…
Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2021 and Business Highlights
Acumen’s investigational drug, ACU193, is the first humanized monoclonal antibody discovered and developed to selectively…
Osmotica Pharmaceuticals plc Reports Second Quarter 2021 Results and Provides Business Update
Sale of legacy business to Alora Pharmaceuticals, LLC expected to close in third quarter 2021…
Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights
Top-line data from ongoing Phase 1 proof of concept clinical trial of TERN-501 expected in…
Eton Pharmaceuticals Reports Second Quarter Financial Results
DEER PARK, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update
– Initiated open label extension for LIFT-AD and ACT-AD trials of ATH-1017 allowing for an…